logo-loader
viewCollagen Solutions PLC

Sale of Strategic Investment in Jellagen

/**/ ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .ad{size:595.3pt 841.9pt;margin:72.3pt 2.0cm 42.55pt 2.0cm;}div.ad{}p.aw{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; margin-bottom: 0cm; text-align: center}p.ax{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: center}span.at{color:black}p.ay{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none}span.aq{font-family:"Calibri","sans-serif";font-weight:normal}span.ap{font-family:"Calibri","sans-serif"}span.ao{font-family: "Calibri","sans-serif";font-weight:normal}p.az{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify} p.ba{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}table.bb{width:487.15pt;margin-left:-8.25pt;border-collapse:collapse}td.ak{width:232.15pt;padding:0cm 5.4pt 0cm 5.4pt}p.bc{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;font-weight: bold; line-height: normal; margin-bottom: 0cm}td.ai{width:233.4pt;padding:0cm 5.4pt 0cm 5.4pt}p.bd{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;margin-bottom:0cm;margin-bottom:.0001pt; line-height:normal}p.be{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";color:#00000A;line-height: normal; margin-bottom: 0cm; text-align: right}span.ag{color:#0070C0}p.bf{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify} /**/
RNS Number : 5300Q
Collagen Solutions PLC
20 February 2019
 

Collagen Solutions Plc

("Collagen Solutions" or the "Company")

 

Sale of Strategic Investment in Jellagen

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it has sold its stake in Jellagen Ltd ("Jellagen") for approximately £215,000 in a private transaction.

 

Jellagen is a private marine biotechnology company founded in 2013 focused on developing collagen biomaterials from jellyfish. Collagen Solutions had held a minority equity position in Jellagen since 2014 and also collaborated on technology development. The transaction to sell Collagen Solutions' shares in Jellagen followed the most recent investment round in Jellagen in which the Company did not participate.

 

Jamal Rushdy, CEO, commented, "We remain interested in Jellagen's progress as it continues to develop its jellyfish collagen cell culture products for the research markets, and our decision to divest our shares does not preclude future potential opportunities to collaborate with Jellagen. We are pleased with our return on this investment, which we can use to further support our own growth opportunities."

 

 

Enquiries: 

 

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected] 

Anna Dunphy

Mob: 07876 741 001

Helen Cresswell

Mob: 07841 917 679

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRABRGDDGBBBGCC

Quick facts: Collagen Solutions PLC

Price: 3.65

Market: LSE
Market Cap: £16.19 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Collagen Solutions sees clear path to profitability as commercial...

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence talk Proactive London's Andrew Scott through the firm's results for the year ended 31 March 2019. Revenues were up 22% in the year at £4.5mln, while its loss narrowed by just under £500,000 to £1.22mln. The core...

on 11/7/19